|
1
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo X and Cui Z: Current diagnosis and
treatment of pancreatic cancer in China. Pancreas. 31:13–22. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang S, Bonaroti J, Unlu S, et al:
Sweating the small stuff: MicroRNAs and genetic changes define
pancreatic cancer. Pancreas. 42:740–759. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Kampen JG, Marijnissen-van Zanten MA,
Simmer F, van der Graaf WT, Ligtenberg MJ and Nagtegaal ID:
Epigenetic targeting in pancreatic cancer. Cancer Treat Rev.
40:656–664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wood LD and Hruban RH: Genomic landscapes
of pancreatic neoplasia. J Pathol Transl Med. 49:13–22. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu WK, Lee CW, Cho CH, et al: MicroRNA
dysregulation in gastric cancer: a new player enters the game.
Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs-the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ikenaga N, Ohuchida K, Mizumoto K, et al:
MicroRNA-203 expression as a new prognostic marker of pancreatic
adenocar-cinoma. Ann Surg Oncol. 17:3120–3128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Izumchenko E, Chang X, Michailidi C, et
al: The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated
kinase switch that induces resistance to EGFR inhibitors. Cancer
Res. 74:3995–4005. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feldman JD, Vician L, Crispino M, et al:
KID-1, a protein kinase induced by depolarization in brain. J Biol
Chem. 273:16535–16543. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Konietzko U, Kauselmann G, Scafidi J, et
al: Pim kinase expression is induced by LTP stimulation and
required for the consolidation of enduring LTP. EMBO J.
18:3359–3369. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li YY, Popivanova BK, Nagai Y, Ishikura H,
Fujii C and Mukaida N: Pim-3, a proto-oncogene with
serine/threonine kinase activity, is aberrantly expressed in human
pancreatic cancer and phosphorylates bad to block bad-mediated
apoptosis in human pancreatic cancer cell lines. Cancer Res.
66:6741–6747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li YY, Wu Y, Tsuneyama K, Baba T and
Mukaida N: Essential contribution of Ets-1 to constitutive Pim-3
expression in human pancreatic cancer cells. Cancer Sci.
100:396–404. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang M, Kanwar N, Feng E, et al: PIM
kinase inhibitors downregulate STAT3 (Tyr705) phosphorylation. Mol
Cancer Ther. 9:2478–2487. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jass JR, Sobin LH and Watanabe H: The
World Health Organization's histologic classification of
gastrointestinal tumors. A commentary on the second edition.
Cancer. 66:2162–2167. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu B, Wang Z, Li HY, Zhang B, Ping B and
Li YY: Pim-3 promotes human pancreatic cancer growth by regulating
tumor vasculogenesis. Oncol Rep. 31:2625–2634. 2014.PubMed/NCBI
|
|
19
|
Yang FQ, Zhang HM, Chen SJ, Yan Y and
Zheng JH: MiR-506 is down-regulated in clear cell renal cell
carcinoma and inhibits cell growth and metastasis via targeting
FLOT1. PloS One. 10:e01202582015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wen SY, Lin Y, Yu YQ, et al: miR-506 acts
as a tumor suppressor by directly targeting the hedgehog pathway
transcription factor Gli3 in human cervical cancer. Oncogene.
34:717–725. 2015. View Article : Google Scholar
|
|
21
|
Liu G, Sun Y, Ji P, et al: MiR-506
suppresses proliferation and induces senescence by directly
targeting the CDK4/6-FOXM1 axis in ovarian cancer. J Pathol.
233:308–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arora H, Qureshi R and Park WY: miR-506
regulates epithelial mesenchymal transition in breast cancer cell
lines. PLoS One. 8:e642732013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin M, Ren X, Zhang X, et al: Selective
killing of lung cancer cells by miRNA-506 molecule through
inhibiting NF-κB p65 to evoke reactive oxygen species generation
and p53 activation. Oncogene. 34:691–703. 2015. View Article : Google Scholar
|
|
24
|
Streicher KL, Zhu W, Lehmann KP, et al: A
novel oncogenic role for the miRNA-506–514 cluster in initiating
melanocyte transformation and promoting melanoma growth. Oncogene.
31:1558–1570. 2012. View Article : Google Scholar
|
